Kore Private Wealth’s Kyntra Bio KYNB Stock Holding History

Kore Private Wealth’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2	Closed	-$1K	–	539
2020 Q2	$1K	Buy	+2	New	+$1.86K	﹤0.01%	1092

Other funds holding KYNB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Kore Private Wealth's KYNB Position: Q3 2020 in Review

Kore Private Wealth sold out of Kyntra Bio (KYNB) in Q3 2020, closing a stake of 2 shares — an estimated $1K sold.

Kore Private Wealth first reported a position in KYNB in Q2 2020 and held it in 1 quarter. The position peaked at $1K in Q2 2020. 208 funds tracked by Wall St. Rank hold KYNB as of Q3 2020.

Kore Private Wealth reported no remaining Kyntra Bio position as of Q3 2020 after selling out during the quarter.
Kore Private Wealth sold 2 Kyntra Bio shares in Q3 2020, an estimated $1K.
Kore Private Wealth first reported a position in Kyntra Bio in Q2 2020 and held it in 1 quarter.
Kore Private Wealth's Kyntra Bio position peaked at $1K in Q2 2020.
208 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.